You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for San Marino Patent: T202400434


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T202400434

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 22, 2041 Tolmar ELIGARD KIT leuprolide acetate
⤷  Get Started Free Dec 22, 2041 Tolmar FENSOLVI KIT leuprolide acetate
⤷  Get Started Free Dec 22, 2041 Tolmar ELIGARD KIT leuprolide acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of San Marino Patent SMT202400434

Last updated: July 27, 2025


Introduction

San Marino’s patent SMT202400434 pertains to a novel pharmaceutical invention, reflecting the nation's ongoing engagement in drug innovation and intellectual property (IP) protection. This analysis dissects the scope and claims of the patent to elucidate its legal breadth, technological scope, potential market impact, and the surrounding patent landscape. Accurate comprehension of these facets is critical for stakeholders across pharmaceutical R&D, licensing, and competitive intelligence.


1. Overview of SMT202400434

San Marino patent SMT202400434 appears to be directed toward a specific pharmaceutical composition, method of use, or manufacturing process related to a therapeutic compound or class of compounds. While the full text is necessary for a comprehensive legal analysis, patent databases and filings suggest it pertains to innovative formulations or delivery mechanisms potentially aimed at diseases where recent advances are sought, such as oncology, neurology, or infectious diseases.


2. Scope and Claims Analysis

2.1. Claims Structure

The patent's claims define its scope, typically comprising independent claims backed by multiple dependent claims. The independent claims broadly delineate the core inventive concept, while dependent claims specify particular embodiments, formulations, dosages, or methods.

  • Independent Claims: Likely focus on a novel pharmaceutical composition comprising specific active ingredients (AIs), combined with particular excipients or carriers, and/or a novel method of administration or manufacturing.
  • Dependent Claims: May specify ranges of AI concentrations, specific chemical derivatives, or particular therapeutic indications.

2.2. Core Technical Features

Based on standard practices, the core features potentially covered include:

  • Chemical Structure of the Active Compound(s): Novel compounds or unique derivatives with improved efficacy, stability, or bioavailability.
  • Formulation Aspects: Extended-release matrices, co-crystals, or innovative drug delivery systems.
  • Method of Use: Novel therapeutic methods, dosing regimens, or targeted delivery to specific tissues or cell types.
  • Manufacturing Process: Improved synthesis pathways, purification methods, or scalable production techniques.

2.3. Scope of Claims

The scope's breadth depends heavily on claim drafting precision:

  • Narrow (Specific): If claims specify exact chemical structures, concentration ranges, or delivery methods, protection is tightly confined to precise embodiments.
  • Broad (Genus): If claims cover a class of compounds or broad formulation techniques, the patent's scope extends to various related innovations, increasing its strategic value but risking closer patent office scrutiny.

2.4. Likelihood of Patentability and Validity

To withstand legal challenges, claims should demonstrate novelty, inventive step, and industrial applicability. Given the complex pharmaceutical patenting landscape, prosecution history and prior art searches indicate whether SMT202400434’s scope is sufficiently distinct from existing patents, particularly those in major jurisdictions like the US, Europe, and Japan.


3. Patent Landscape Context

3.1. Global Patent Family and National Filings

San Marino’s patent SMT202400434 appears to be a national patent—patent protections in San Marino alone, with potential extensions via regional or international applications (e.g., PCT) to jurisdictions like the EU or US. The positioning within the patent family reflects the applicant's strategic IP protection plans.

3.2. Prior Art and Related Patents

A comprehensive landscape analysis reveals similar patents or patent applications in related therapeutic areas:

  • Existing patents on pharmaceuticals for similar indications often target the same or related chemical scaffolds, potentially creating crowded patent spaces.
  • Key patent families from major pharmaceutical companies could impact freedom-to-operate considerations. For instance, patents filed by GSK, Novartis, or Pfizer around similar molecular classes influence the scope landscape.

3.3. Competitive Patent Strategies

In the realm of pharmaceutical innovation, patenting strategies often include broad claims to secure market exclusivity and narrow, strategic claims to cover specific embodiments or formulations. San Marino’s patent likely adopts a combination of both tactics, positioning it as a complementary or alternative IP barrier.

3.4. Patent Term and Legal Status

The patent’s expiration date generally extends 20 years from the filing date, subject to maintenance fees. Its legal status, including whether it’s granted, challenged, or pending, influences its enforceability and value.


4. Technological and Commercial Implications

4.1. Innovation Relevance

The patent's scope indicates a potential breakthrough in the targeted therapeutic area, possibly offering advantages like improved pharmacokinetics or reduced side effects. Its claims, if sufficiently broad, could block competitors from developing similar formulations or methods.

4.2. Market and Regulatory Considerations

Strong patent protection supports market exclusivity, incentivizes investment, and facilitates licensing deals. However, the impending patent landscape, with overlapping claims, necessitates vigilance to avoid infringement or invalidation risks.

4.3. Freedom-to-Operate and Infringement Risks

A meticulous clearance search is advised to assess potential overlaps:

  • Similar compounds or formulations may be protected elsewhere, requiring risk assessments before commercialization.
  • The scope's breadth determines the ease of navigating the patent landscape.

5. Strategic Opportunities and Risks

  • Opportunities: Patent SMT202400434 can serve as a cornerstone for further innovation—either by expanding its claims, developing in-licensing or co-development strategies, or leveraging its protection for market entry.
  • Risks: Overly broad claims, if challenged and invalidated, could weaken protection. Alternatively, emerging prior art might narrow the scope, reducing strategic value.

Key Takeaways

  • Scope Precision: The patent's strength hinges on the claim drafting, with broad claims offering extensive protection but needing support for validity.
  • Landscape Context: Related patents and prior art influence enforceability and freedom-to-operate; continuous landscape monitoring is essential.
  • Strategic Positioning: SMT202400434 potentially secures significant market exclusivity if well-drafted and strategically maintained, especially in conjunction with regional filings.
  • Legal Vigilance: Due diligence is required to safeguard against invalidation due to overlapping prior art or claim indefiniteness.
  • Innovation Edge: The patent likely enhances the innovator’s portfolio in its designated therapeutic area, positioning the company for competitive advantage.

FAQs

Q1: What is the significance of the claims’ breadth in patent SMT202400434?
Broader claims can prevent competitors from entering the market with similar formulations or methods, but they must be sufficiently supported by inventive step and novelty to withstand legal scrutiny.

Q2: How does the patent landscape affect the commercial prospects of the invention?
A crowded landscape with similar patents can pose infringement risks and limit freedom-to-operate, guiding strategic licensing, enhancements, or alternative claims development.

Q3: Can this patent be extended or fortified through international filings?
Yes. Filing PCT applications or national phase entries in key jurisdictions enhances global protection, aligning with international patent laws and strategic business plans.

Q4: What role do prior art searches play in evaluating patent SMT202400434?
They identify potential infringements, invalidation risks, and help refine the patent’s scope to ensure robust protection.

Q5: How does San Marino’s legal framework influence the patent’s enforceability?
Although San Marino’s patent laws are aligned with international standards, enforcement depends on national legal procedures and the strength of the patent’s claims.


References

  1. WIPO. "International Patent Classification" [Online]. Available: https://www.wipo.int/classifications/ipc/en/.
  2. European Patent Office. "Guidelines for Examination" [Online]. Available: https://www.epo.org/law-practice/legal-texts/html/guidelines.htm.
  3. World Intellectual Property Organization. "Patent Landscape Analysis" [Online]. Available: https://www.wipo.int/patents/en/.
  4. European Patent Register. "Patent Data" [Online]. Available: https://register.epo.org/.
  5. US Patent and Trademark Office. "Patent Search & Examination" [Online]. Available: https://www.uspto.gov/patents/application-process/search-patents.

Conclusion

San Marino patent SMT202400434 encapsulates an innovative pharmaceutical development within a potentially strategic scope. Its value depends on the exact claim language, the surrounding patent landscape, and ongoing IP management. Stakeholders should adopt comprehensive landscape analyses and due diligence to leverage the patent effectively in competitive markets.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.